"Designing Growth Strategies is in our DNA"

Asia Pacific Dry Eye Syndrome Market Size, Share & COVID-19 Impact Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2023-2030

Last Updated: March 03, 2025 | Format: PDF | Report ID: FBI107541

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Dry Eye Disease, by Key Countries, 2022
    2. Key Industry Developments
    3. New Product Launches
    4. Reimbursement Policies
    5. Regulatory Scenario
    6. Healthcare Industry Overview, by Key Countries
    7. Impact of COVID-19 on Global Dry Eye Syndrome Market
  5. Asia Pacific Dry Eye Syndrome Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Anti-inflammatory
        1. Cyclosporine
        2. Corticosteroids
        3. Others
      2. Artificial Tears and Lubricants
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    3. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  6. Competitive Analysis
    1. Asia Pacific Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Alcon
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Santen Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. OASIS Medical
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. Financials (Based on Availability)
      6. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sentiss Pharma Pvt. Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. VISUfarma
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Product, 2022 & 2030

Figure 2:  Asia Pacific Dry Eye Syndrome Market Value Share (%), by Product, 2022

Figure 3:  Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 4:  Asia Pacific Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2022

Figure 5:  Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 6:  Asia Pacific Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2022

Table 1:  Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2019-2030

Table 2: Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory, 2019-2030

Table 3:  Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 4:  Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

Asia Pacific Dry Eye Syndrome Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 109
Consulting Services
    How will you benefit from our consulting services ?